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Nontyphoidal	Salmonella	 is	 a	major	 cause	 of	 bloodstream	
infections	worldwide,	and	HIV-infected	persons	and	malaria-
infected	and	malnourished	children	are	at	increased	risk	for	
the	disease.	We	conducted	a	systematic	literature	review	to	
obtain	age	group–specific,	population-based	invasive	nonty-
phoidal	Salmonella	(iNTS)	incidence	data.	Data	were	catego-
rized	by	HIV	and	malaria	prevalence	and	then	extrapolated	by	
using	2010	population	data.	The	case-fatality	ratio	(CFR)	was	
determined	by	expert	opinion	consensus.	We	estimated	that	
3.4	(range	2.1–6.5)	million	cases	of	iNTS	disease	occur	an-
nually	(overall	incidence	49	cases	[range	30–94]	per	100,000	
population).	Africa,	where	infants,	young	children,	and	young	
adults	 are	 most	 affected,	 had	 the	 highest	 incidence	 (227	
cases	[range	152–341]	per	100,000	population)	and	number	
of	cases	(1.9	 [range	1.3–2.9]	million	cases).	An	 iNTS	CFR	
of	20%	yielded	681,316	(range	415,164–1,301,520)	deaths	
annually.	iNTS	disease	is	a	major	cause	of	illness	and	death	
globally,	particularly	in	Africa.	Improved	understanding	of	the	
epidemiology	of	iNTS	is	needed.
Nontyphoidal Salmonella (NTS) disease, a major cause of diarrheal disease globally, is estimated to cause 
93 million enteric infections and 155,000 diarrheal deaths 
each year (1). The Institute for Health Metrics and Evalua-
tion estimated that enteric NTS disease was associated with 
4,847,000 disability-adjusted life years lost (70 disability-
adjusted life years/100,000 population) and 81,300 diar-
rheal deaths (1.2 deaths/100,000 population) in 2010 (2,3). 
However, these estimates do not include invasive NTS 
(iNTS) disease, which is often not associated with diarrhea. 
A systematic review of community-acquired bloodstream 
infections in Africa showed that 29% were caused by 
Salmonella enterica, and a high proportion of these infec-
tions in some parts of Africa were caused by NTS: 88% in 
eastern Africa, 97% in southern Africa, and 87% in west-
ern and central Africa, compared with only 1% in northern 
Africa (4). Moreover, this review identified that the 2 most 
common serovars causing iNTS infections were S. enterica 
serovars Typhimurium and Enteritidis, which accounted 
for 65.2% and 33.1%% of all NTS serotyped isolates, re-
spectively (4). iNTS disease appears to be more common 
in some parts of Africa than in other regions of the world 
(5). Host risk factors appear to play a major role in the epi-
demiology of iNTS disease in Africa (6), where the disease 
is closely associated with malaria and malnutrition among 
infants and children (7–9) and with HIV infection among 
adults (4,10,11).
An estimate of the global and regional burden of iNTS 
disease is needed to inform and stimulate efforts to pre-
vent and manage the disease. Estimation of illness and 
death due to iNTS disease has been limited by a scarcity of 
population-based surveillance data on bloodstream infec-
tions, particularly in Africa. However, the availability of 
high-quality country-level data on 2 major host risk factors 
for iNTS (i.e., HIV and malaria [6]) provides a basis for 
extrapolation of the few population-based iNTS surveil-
lance data that are available for other areas. We sought to 
estimate the global incidence of iNTS disease by age and 
region and to calculate the number of illnesses and deaths 
by extrapolating credible population-based incidence data 
and incorporating the effects of HIV and malaria to account 
for differences in the population at risk among countries.
Materials and Methods
Systematic Literature Review for iNTS Incidence Data
We conducted a systematic review for iNTS incidence 
data by following guidelines of the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (12). 
We used standard primary search terms (Salmonella, 
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Typhi/typhoid, Paratyphi/paratyphoid, non-typhoidal, 
foodborne, diarrhea, Typhimurium, and Enteritidis) and 
standard secondary search terms (morbidity, incidence, 
prevalence, sequelae, mortality, mode of transmission, 
outbreak, invasive, bacteremia, septicemia/septicemia, 
bloodstream infection, invasive, CSF/cerebral spinal flu-
id, bone marrow, and blood culture) in the following da-
tabases: PubMed, System for Information on Grey Litera-
ture in Europe, World Health Organization library, Food 
and Agriculture Organization of the United Nations, and 
Bath Information and Data Services. Each primary search 
term was combined with all secondary search terms by 
using the AND operator. The time period for the search 
was January 1990–December 2012.
The types of studies included population-based inci-
dence studies, population-based surveillance systems, and 
national surveillance data. We consulted with a US Centers 
for Disease Control and Prevention (Atlanta, GA, USA) li-
brarian during the development of the searches. Two teams 
of reviewers, each led by a co-author (T.T.A. or J.A.C.) 
and assisted by S.H. or D.B. (see Acknowledgments), pro-
cessed the citations for relevant publications in 3 stages: 
title, abstract, and full-text review. If there was a disagree-
ment during any stage, a tie-breaker from the other team 
(T.T.A. or J.A.C.) decided if the publication was appro-
priate. We included foreign language articles that had at 
least an English translation of the title for the first stage of 
review. If a citation met the requirement at this stage, we 
looked for the English translation of the abstract for the 
second and subsequent stages.
Extrapolation of Incidence to All Age Groups
We sought to obtain incidence data for all age groups. 
For studies identified through the systematic review that 
did not have incidence data for all age groups, we created 
incidence profile curves to extrapolate the available inci-
dence data to other age groups in that particular popula-
tion by using proportion curves that were calculated from 
2 sources that had complete case counts for each age group 
(Figure 1): US FoodNet (Foodborne Diseases Active Sur-
veillance Network) data (low iNTS incidence profile) (13) 
and Malawi and South Africa surveillance data (high iNTS 
incidence profile) (14). We divided the number of cases in 
the available age groups by the total number of cases and 
used these age-specific proportions and either the low or 
high incidence profile, according to that country’s iNTS 
epidemiologic pattern, to extrapolate the incidence to the 
other age groups in that population. This yielded all age 
group iNTS incidence data for all studies identified in the 
systematic review (Figure 2).
Assignment of iNTS Incidence Data to 3-Level  
Matrix of HIV and Malaria Prevalence
We then assigned the iNTS incidence data identified from 
the systematic review to a 3 × 3 matrix based on the HIV 
seroprevalence and malaria population at risk category of 
the country of origin of the iNTS incidence data (Figure 3). 
When necessary, age incidence curves from the same matrix 
were also used to extrapolate data to all age groups. For HIV 
categorization in the matrix, we used the 2009 UNAIDS 
(Joint United Nations Program on HIV/AIDS) country-
specific seroprevalence data (15) and classified countries 
into low (0 to <5.0%), moderate (5.0% to 10.0%), and high 
(>10.0%) HIV seroprevalence. For malaria categorization in 
the matrix, we used the Malaria Atlas Project country-spe-
cific population at risk for malaria (16,17). The population at 
risk is defined as the proportion of the total population living 
in an area of known Plasmodium falciparum transmission. 
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Figure 1.	Proportion	of	invasive	
nontyphoidal	Salmonella 
disease,	by	age	group,	from	
low-incidence	settings	in	
the	United	States	and	high-
incidence	settings	in	Malawi	
and	South	Africa.
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Countries were classified as having low (0%), moderate 
(0.1%–10.0%), or high (>10.0%) proportions of their popu-
lations at risk for malaria. Each of the iNTS incidence data 
points from the systematic review (extrapolated to all age 
groups as described above) were assigned within the matrix, 
depending on the HIV and malaria epidemiology in the coun-
try source of the data. If a matrix cell had >1 data source after 
the iNTS incidence data were assigned, the mean incidence 
from all sources was calculated as the reference incidence 
for that matrix cell. A minimum to maximum range was also 
identified by using the respective values within a specific age 
group. If a matrix cell had only 1 incidence reference, the 
minimum and maximum incidences were calculated by us-
ing the median to mean ratio of cell A (Figure 3). If a cell did 
not have a source, we extrapolated incidence rates by using 
existing data, with the assumption that the middle cell was 
the mean of the 2 cells on either side. As shown in Figure 3, 
we first extrapolated cell C by assuming that cell B was the 
mean of cells A and C. Then we proceeded to calculate cells 
D, G, and H by using the same assumption. This yielded a 
reference all age group incidence rates for each cell in the 3 
× 3 matrix (Figure 4).
Extrapolation to All Countries Worldwide
For the last round of extrapolation, we assigned all countries 
worldwide to a cell in the 3 × 3 matrix according to each 
country’s HIV seroprevalence and malaria population at 
risk. We then calculated the number of iNTS cases for each 
country by using the reference incidence rates from the cell, 
according to the assignment of each country in the matrix 
and each country’s population stratified by age groups. We 
used the United Nation’s population data for 2010, medium 
variant, grouped by World Health Organization regions (18). 
Country classification by region, HIV, and malaria profile 
is available in online Technical Appendix 1 (http://wwwnc.
cdc.gov/EID/article/21/6/14-0999-Techapp1.xlsx).
Case-Fatality Ratio and Number of Deaths
We conducted an additional literature review to iden-
tify reports of case-fatality ratios (CFRs) due to iNTS. 
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Figure 2.	Incidence	of	
invasive	nontyphoidal	
Salmonella	disease,	by	age	
group,	in	countries	with	 
data	identified	through	a	
global	systematic	review	of	
the	literature.	
Figure 3.	HIV	and	malaria	burden	matrix	and	extrapolation	
strategy	used	to	create	reference	age-specific	incidence	curves	
for	invasive	nontyphoidal	Salmonella	disease.	*2010	Joint	 
United	Nations	Program	on	HIV/AIDS	(UNAIDS)	HIV	
seroprevalence	(15);	†Malaria	Atlas	Project	population	at	risk	
estimate,	defined	as	the	proportion	of	the	population	living	in	 
	an	area	of	known	Plasmodium falciparum	transmission	(16,17);	
‡US	FoodNet	(13).
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In addition, we solicited expert opinions in person at 
the 8th International Conference on Typhoid Fever and 
Other Invasive Salmonelloses in Dhaka, Bangladesh, 
2013, and by email to develop a consensus CFR. We 
asked experts to provide a single value, taking into ac-
count variations by co-infections, geography, age, in-
fection rate, strain type, and study setting (i.e., hospital 
based vs. community based). The consensus CFR was 
then applied to the estimated number of iNTS cases and 
the minimum and maximum range to estimate iNTS 
deaths and minimum and maximum range. We also 
varied the CFR to understand the effect of the consensus 
CFR on global iNTS deaths. To understand the effect 
of the consensus CFR, we performed a sensitivity analy-
sis by applying the range of CFRs found in the system-
atic review.
Results
We identified 9,739 unique citations, 2,029 (20.8%) of 
which were from non–English language journals. We ex-
cluded 9,011 by title screening alone. Of the remaining 
728 citations, 700 were excluded by abstract screening. 
Of the remaining 28 potential eligible citations with 
relevant abstracts, 10 were eligible for full text review 
(Figure 5; Table 1). 
We found substantial geographic variation in age-specific 
incidence (Figure 2). Overall, Kenya and Malawi had higher 
incidence rates across all age groups compared with other 
countries. There was a bimodal distribution of incidence for 
these 2 locations, with peaks among for children <5 years of 
age and adults 30–35 years of age. In addition, for children <5 
years of age, the incidence of disease for Kenya and Malawi 
was at least 3 times as high as that for other locations.
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Figure 4. Age-specific	invasive	nontyphoidal	Salmonella	disease	incidence	(cases/100,000	population)	for	various	HIV	and	
malaria	settings,	2010.	Number	at	lower	right	corner	of	each	chart	represents	the	number	of	countries	in	the	category.	Incidence	
is	cases/100,000	population.	Solid	lines	on	each	graph	represent	the	estimated	age-specific	invasive	nonthyphoidal	Salmonella 
(iNTS)	disease	incidence;	dotted	lines	represent	ranges.	A	country	is	classified	into	1	of	the	8	categories	on	the	basis	of	national	HIV	
seroprevalence	and	malaria	population	at	risk.	The	age-specific	iNTS	incidence	in	that	category	(solid	line	in	graph)	is	then	applied	
to	the	country’s	population	data	to	determine	the	number	of	cases	and	overall	incidence	of	iNTS	for	the	country.	*2010	Joint	United	
Nations	Program	on	HIV/AIDS	HIV	seroprevalence	(15);	†Malaria	Atlas	Project	population	at	risk	estimate,	defined	as	the	proportion	
of	the	population	living	in	an	area	of	known	Plasmodium falciparum	transmission	(16,17).	
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We estimate 3.4 (range 2.1–6.5) million cases of iNTS 
disease each year and an overall incidence of 49 (range 
30–94) cases/100,000 population (Table 2). Africa has the 
highest incidence of iNTS disease (227 [range 152–341] 
cases/100,000 population) and the largest number of cases 
(1.9 [range 1.3–2.9]) million cases). The age group–spe-
cific incidence rate proportion profile graphs for 8 HIV 
and malaria scenarios suggest substantial changes in iNTS 
incidence rates as the HIV prevalence and proportion of 
population at risk for malaria increase (Figure 4). Most 
countries in the world (69%) belong to the low malaria and 
low HIV category. Among iNTS cases, 63.7% occurred in 
children <5 years of age globally, and 68.3% occurred in 
children <5 years of age in Africa. The global incidence 
ratio of enteric disease to invasive disease was 28:1 (range 
14–45:1) (Table 2), indicating that for every iNTS case 
there were 28 enteric NTS cases. This ratio is highest in 
Asia and Oceania (3,851:1, range 1,317–23,806:1) and 
lowest in Africa (1:1, range 1–2:1).
CFR
A range of potential CFRs, from 3% (27) to 47% (28), was 
identified by the systematic review. Expert opinion identi-
fied a most likely CFR of 20%. Using a CFR of 20%, we 
estimated that 681,316 (range 415,165–1,301,520) deaths 
would result from the annual number of cases. Varying the 
CFR demonstrated a possible range of numbers of deaths 
due to iNTS from 102,197 at 3% CFR (range 62,275–
195,228) to 1,703,290 at 50% CFR (range 1,037,912–
3,253,800) (Table 3).
Discussion
We estimate that 3.4 (range 2.1–6.5) million cases of iNTS 
disease occurred in 2010, with a CFR of 20%, for an over-
all incidence of 49 (range 30–94) cases/100,000 population 
and 681,316 (range 415,164–1,301,520) deaths. For com-
parison, globally there were ≈1.2 million malaria-associat-
ed deaths and 1.5 million HIV-associated deaths in 2010 
(29). Compared with the estimated number of 93.7 million 
enteric NTS illnesses in 2010, the number of iNTS cases is 
considerably lower (1). However, because of the high esti-
mated CFR for iNTS, the number of deaths resulting from 
this disease (681,316 deaths) is considerably higher than 
that estimated for enteric NTS (155,000 deaths). Further-
more, the estimated number of deaths due to typhoid fever 
in 2000 was 216,510 (30), and the estimated number for 
typhoid and paratyphoid fever in 2010 was 190,200 (29).
The highest number of iNTS cases occurred in Af-
rica, where in 2010, almost 2 million illnesses (227 cas-
es/100,000 population) occurred, accounting for more than 
half of global cases. The region with the second highest 
number of cases in 2010 was Europe (763,191 cases cas-
es/100,000 population), but the number was substantially 
lower than that for Africa. The high number of cases in 
Europe is mainly driven by cases in Russia, Ukraine, and 
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Figure 5.	Results	of	a	systematic	review	of	the	literature	for	the	
global	burden	of	invasive	nontyphoidal	Salmonella	disease.	Reports	
published	during	January	1990–December	2012	were	searched.	
 
 
 
Table 1. Eligible	studies	of	iNTS from	systematic	literature	review,	1990–2012* 
Reference Time	of	study Country	(city) Median	iNTS cases/100,000	population	(range) 
Berkley	et	al.	(19) 1998–2002 Kenya	(Kilifi) 8	(4–1,457) 
Tabu	et	al.	(8) 2006–2009 Kenya Lwak,	232	(24–2,085);	Kibera,	0	(0–260) 
Nadjm	et	al.	(20) 2006–2007 Tanzania 7	(0–130) 
Mtove	et	al.	(21) 2006–2010 Tanzania 5	(0–82) 
Sigaúque	et	al.	(22) 2001–2006 Mozambique 22	(1–388) 
Feasey	et	al.	(14) 1998–2004 Malawi,	South	Africa South	Africa,	1.6	(0.3–7.2);	Malawi,	84	(2–1,963) 
Enwere	et	al.	(23) 2000–2004 The	Gambia 17	(1–300) 
Khan	et	al.	(24) 2001–2003 China,	India,	Indonesia,	
Pakistan,	Viet	Nam 
Pakistan,	1.6	(1.2–7.2);	Indonesia,	0.2	(0.2–1.0);	India,	0.05	
(0.03–1.8) 
Gradel	et	al.	(25) 1994–2003 Denmark 1.9	(0–9.6) 
Laupland	et	al.	(26) 2000–2007 Finland,	Australia,	Denmark,	
Canada 
Finland,	0.2	(0.1–7.6);	Calgary,	Canada,	0.2	(0.1–6.5);	
Denmark,	0.4	(0.3–1.9);	Sherbrooke,	Canada,	0.5	(0.4–2.2);	
Victoria,	Canada,	0.07	(0.05–0.3);	Australia,	0.1	(0.09–0.5) 
*iNTS,	invasive	nontyphoidal	Salmonella disease.  
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Estonia, 3 eastern European countries with large popula-
tions and relatively higher iNTS incidence profiles com-
pared with those for countries in western Europe. Our find-
ings, together with contemporary longitudinal descriptive 
literature, provide additional evidence that a largely under-
appreciated epidemic of iNTS has been occurring in Africa, 
driven in part by co-infection with HIV or malaria. Anti-
microbial drug resistance emerging across the continent is 
likely to influence the incidence of iNTS and associated 
deaths (31,32).
The incidence of iNTS is highest among children and 
young adults in sub-Saharan Africa. These groups should 
be a high priority for prevention efforts, including a poten-
tial NTS vaccine (33). Efforts to advance vaccines against 
the most prevalent serotypes of NTS, Salmonella serovars 
Typhimurium and Enteritidis, should be intensified.
Estimates of illness and deaths due to iNTS both in 
sub-Saharan Africa and globally are likely to be inaccurate 
(6,34). Invasive bacterial disease surveillance is essential 
for identifying cases and monitoring iNTS trends, yet it 
is not widely available in disease-endemic areas (35). As 
demonstrated by this review, few invasive bacterial disease 
surveillance studies have been conducted that can provide 
population-based incidence data. Most published articles 
identified by the literature search were clinical reports or 
case series. Population-based incidence data are vital for 
future refinements of our estimates.
Sources and modes of transmission of NTS in Africa 
are also poorly understood. The development of nonvac-
cine prevention efforts will require a more in-depth under-
standing of the basic epidemiology of NTS on the conti-
nent (34,36). It is possible that the relative importance of 
transmission through food, water, and contact with animals 
and their environments differs from patterns observed for 
enteric NTS infection in industrialized nations. Further-
more, genomic studies (37) and integrated human and ani-
mal studies (38) raise the hypothesis that infected humans 
may be an important source of infection. There is also evi-
dence that in South Africa iNTS is often associated with 
health care facilities (39,40).
Invasive NTS is a leading cause of invasive bacte-
rial disease in Africa. This finding has a range of impli-
cations for patient management. It is vital that recom-
mendations for empiric management of sepsis incorporate 
antimicrobial agents suitable for the management of iNTS. 
Not only are aminoglycosides inappropriate for intracellu-
lar infections, such as iNTS, but resistance to traditional 
first-line drugs (ampicillin, trimethoprim sulfamethoxazole, 
and chloramphenicol) is now common among iNTS strains 
in Africa (4). Of further concern, resistance to traditional 
first-line drugs among iNTS strains in Asia occurs along-
side resistance to fluoroquinolones and extended-spectrum 
cephalosporins in some areas (41 in online Technical Ap-
pendix 2, http://wwwnc.cdc.gov/EID/article/21/6/14-0999-
Techapp2.pdf). Antimicrobial resistance appears to have 
played a role in the emergence and proliferation of indi-
vidual NTS serovars and strains in populations at risk for 
infection (31,32). In sub-Saharan Africa, evidence suggests 
that Salmonella Typhimurium ST313 has developed mul-
tiple drug resistance and has adapted itself to immunosup-
pressed persons, particularly those living with HIV. Pre-
vention and management of host conditions predisposing 
to iNTS are also likely to be key to the control of iNTS. 
Reductions in malaria transmission have been ecologically 
associated with declines in iNTS disease in some areas (21) 
(42,43 in online Technical Appendix 2). Declines in HIV 
seroprevalence and reductions in the proportion of HIV-
infected persons with low CD4-positive T-lymphocyte 
946	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	21,	No.	6,	June	2015
 
 
 
Table 2. Global	burden	of	invasive	nontyphoidal	Salmonella disease,	2010,	compared	with	enteric	nontyphoidal	Salmonella disease,	
2009* 
Region 
Enteric	nontyphoidal	Salmonella,	2009† 
 
Invasive	nontyphoidal	Salmonella,	2010 
 Ratio of enteric 
to	invasive	
disease	(range) 
Population, 
thousands No.	cases 
Cases/	
100,000	
population 
Population, 
thousands No.	cases	(range) 
Cases/100,000	
population	
(range) 
N.	Africa,	
MidEast 
410,800 563,000 140  446,721 3,617	(66010,483) 0.8	(0.1–2.3) 156:1	(54–853:1) 
Africa 767,239 2,458,000 320  854,091 1,942,776	 
(1,301,399–2,910,768) 
227	(152–341) 1:1	(1–2:1) 
Asia,	
Oceania 
1,628,815 53,610,000 3,280  1,693,046 13,920	 
(2,252–40,711) 
0.8	(0.13–2.4) 3,851:1	 
(1,317–23,806:1) 
SE	Asia 2,072,274 29,839,000 1,440  2,220,248 472,263	 
(110,992–2,045,128) 
21	(5–92) 63:1	(15–269:1) 
Europe 738,071 5,065,000 690  746,372 763,191	 
(515375–1,179,778) 
102	(69–158) 7:1	(4–10:1) 
Americas 888,437 2,222,000 250  934,132 210,811	 
(145,145–320,732) 
23	(16–34) 11:1	(7–15:1) 
Global 6,511,638 93,757,000 1,140  6,894,610 3,406,579	 
(2,075,823–6,507,600) 
49	(30–94) 28:1	(14–45:1) 
*MidEast,	Middle	East;	N.	Africa,	North	Africa;	SE	Asia,	Southeast	Asia. 
†Majowicz	et	al.	(1). 
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counts by successful antiretroviral drug therapy would be 
anticipated to have similar effects on iNTS disease (44,45 
in online Technical Appendix 2).
Our results demonstrate substantial differences in the 
ratio of enteric to invasive disease by geographic area. 
Whereas the incidence of enteric disease is highest in Asia 
and Oceania, the incidence of invasive disease is highest in 
Africa, where the incidence ratio of invasive to enteric dis-
ease was 1:1 (Table 2), which suggests that the magnitude 
of iNTS in Africa is comparable to that of enteric NTS.
Our study has several limitations. First, our rigorous 
systematic search for population-based incidence data in 
the literature resulted in a limited number of eligible sourc-
es. Despite this scarcity of eligible studies, the existing data 
are of high quality and, we believe, representative of the 
settings from where they were collected. Second, we did 
not consider other host risk factors, such as malnutrition 
and sickle cell disease. Excluding the effect of these con-
ditions might result in underestimation of iNTS incidence 
rates and the number of cases and deaths. Third, we as-
sumed that the country-level prevalence for the HIV- and 
malaria-infected population at risk is uniform, even though 
there is likely considerable subnational variation for these 
measures. Fourth, we did not take into account the declines 
in malaria worldwide in the past decade, nor did we ac-
count for changes in HIV seroprevalence and progress with 
provision of care and treatment globally. We used the most 
contemporary HIV and malaria data available. However, 
iNTS incidence data used in these estimations may have 
been collected under different HIV seroprevalence and 
malaria population at-risk conditions than those observed 
in 2010. In addition, the incidence curve for the low HIV 
and high malaria grouping had an artificially high peak in 
the 35- to 39-year-old age group, which was due to the as-
sumption we made that, across the rows in our incidence 
reference grid, the middle cell is the average of the 2 cells 
on each side. Because we know that malaria is predomi-
nantly associated with iNTS disease among young chil-
dren, we believe this artifact is a result of our assumption. 
However, because there were only 2 countries in this group 
(Comoros and Madagascar), and we believe that any po-
tential overestimation of incidence in the 35- to 39-year-
old age group in these countries will be negligible. In ad-
dition, HIV and malaria also contribute differently as risk 
factors in different ages in a given population. In popula-
tions with high HIV seroprevalence, the risk factors are 
highest among young adults and persons in younger age 
groups; in high malaria areas, the persons at highest risk for 
iNTS are those <5 years of age.
In the absence of a standard CFR for iNTS, we relied 
on expert opinion to estimate the most likely value. Our 
estimate of deaths from iNTS disease was high compared 
with the estimated number of deaths associated with HIV, 
malaria, and protein energy malnutrition. It is likely that 
many iNTS-associated deaths are currently counted as 
deaths resulting from these underlying conditions. This 
high estimate might have been biased by expert opinions 
from hospital-based studies and experiences, especially in 
established research programs that have better diagnostics 
and appropriate antimicrobial drug treatments and a higher 
level of care than in other settings.
Despite these limitations, we provide a baseline esti-
mate of invasive nontyphoidal Salmonella disease burden 
globally, which is urgently needed to set the scientific and 
policy agenda . We hope that our estimate will be refined in 
the future by incorporating new population-based surveil-
lance data, improved estimates of the CFR, and more so-
phisticated approaches to extrapolation and modeling. We 
have demonstrated that iNTS disease is a major cause of 
illness and death globally, particularly in Africa. Improved 
understanding of the epidemiology of iNTS is needed to 
underpin effective efforts for prevention, control, and im-
proved patient management.
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Table 3. Sensitivity	analysis	of	invasive	nontyphoidal	Salmonella 
disease	case-fatality	ratio,	2010 
Case-fatality	ratio,	% Estimated	no.	annual	deaths	(range) 
3 102,197	(62,275–195,228) 
5 170,329	(103,791–325,380) 
10 340,658	(207,582–650,760) 
20 681,316	(415,165–1,301,520) 
30 1,021,974	(622,747–1,952,280) 
40 1,362,632	(830,329–2,603,040) 
50 1,703,290	(1,037,912–3,253,800) 
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